Exhausted signature and regulatory network of NK cells in myasthenia gravis
Inhibition of IL-6/IL-21/SOCS2/STAT5 pathway and recovery of NK-cell ability to inhibit autoimmunity may be a new direction in the treatment of MG.
Authors
- Qing Zhang (ORCID: https://orcid.org/0000-0002-5094-2747)
- Jing Lin (ORCID: https://orcid.org/0000-0001-5901-0498)
- Zhuajin Bi (ORCID: https://orcid.org/0000-0002-2002-6633)
- Bitao Bu (ORCID: https://orcid.org/0000-0001-5369-7751)
- Mengge Yang (ORCID: https://orcid.org/0000-0001-7623-1022)
- Min Zhang (ORCID: https://orcid.org/0000-0002-1345-0604)
- Zhijun Li (ORCID: https://orcid.org/0000-0002-1378-791X)
- Xingyu Han (ORCID: https://orcid.org/0000-0003-2682-9768)
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.3389/fimmu.2024.1397916
- Citations
- 5
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 1.85
Funders
- National Natural Science Foundation of China